These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 16807654)

  • 1. Identification of factor inhibitors by diagnostic haemostasis laboratories: a large multi-centre evaluation.
    Favaloro EJ; Bonar R; Duncan E; Earl G; Low J; Aboud M; Just S; Sioufi J; Street A; Marsden K;
    Thromb Haemost; 2006 Jul; 96(1):73-8. PubMed ID: 16807654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mis-identification of factor inhibitors by diagnostic haemostasis laboratories: recognition of pitfalls and elucidation of strategies. A follow up to a large multicentre evaluation.
    Favaloro EJ; Bonar R; Duncan E; Earl G; Low J; Aboud M; Just S; Sioufi J; Street A; Marsden K
    Pathology; 2007 Oct; 39(5):504-11. PubMed ID: 17886101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory testing for von Willebrand's disease: an assessment of current diagnostic practice and efficacy by means of a multi-laboratory survey. RCPA Quality Assurance Program (QAP) in Haematology Haemostasis Scientific Advisory Panel.
    Favaloro EJ; Smith J; Petinos P; Hertzberg M; Koutts J
    Thromb Haemost; 1999 Oct; 82(4):1276-82. PubMed ID: 10544913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigations from external quality assurance programs reveal a high degree of variation in the laboratory identification of coagulation factor inhibitors.
    Favaloro EJ; Bonar R; Kershaw G; Duncan E; Sioufi J; Marsden K
    Semin Thromb Hemost; 2009 Nov; 35(8):794-805. PubMed ID: 20169516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory identification of factor VIII inhibitors in the real world: the experience from Australasia.
    Favaloro EJ; Bonar R; Kershaw G; Mohammed S; Duncan E; Marsden K;
    Haemophilia; 2010 Jul; 16(4):662-70. PubMed ID: 20070382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing errors in identification of von Willebrand disease: the experience of the royal college of pathologists of australasia quality assurance program.
    Favaloro EJ; Bonar R; Kershaw G; Sioufi J; Baker R; Hertzberg M; Street A; Marsden K
    Semin Thromb Hemost; 2006 Jul; 32(5):505-13. PubMed ID: 16862524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multilaboratory testing of thrombophilia: current and past practice in Australasia as assessed through the Royal College of Pathologists of Australasia Quality Assurance Program for Hematology.
    Favaloro EJ; Bonar R; Sioufi J; Wheeler M; Low J; Aboud M; Duncan E; Smith J; Exner T; Lloyd J; Marsden K;
    Semin Thromb Hemost; 2005 Feb; 31(1):49-58. PubMed ID: 15706475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The between-laboratory variation of factor VIII inhibitor testing: the experience of the external quality assessment program of the ECAT foundation.
    Meijer P; Verbruggen B
    Semin Thromb Hemost; 2009 Nov; 35(8):786-93. PubMed ID: 20169515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower limit of assay sensitivity: an under-recognised and significant problem in von Willebrand disease identification and classification.
    Favaloro EJ; Bonar R; Marsden K
    Clin Lab Sci; 2008; 21(3):178-83. PubMed ID: 18678140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating laboratory approaches to the identification of lupus anticoagulants: a diagnostic challenge from the RCPA Haematology QAP.
    Bonar R; Favaloro E; Zebeljan D; Rosenfeld D; Kershaw G; Mohammed S; Marsden K; Hertzberg M
    Pathology; 2012 Apr; 44(3):240-7. PubMed ID: 22183703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory assessment of factor VIII inhibitor titer: the North American Specialized Coagulation Laboratory Association experience.
    Peerschke EI; Castellone DD; Ledford-Kraemer M; Van Cott EM; Meijer P;
    Am J Clin Pathol; 2009 Apr; 131(4):552-8. PubMed ID: 19289591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lessons from the organization of a proficiency testing program in food microbiology by interlaboratory comparison: analytical methods in use, impact of methods on bacterial counts and measurement uncertainty of bacterial counts.
    Augustin JC; Carlier V
    Food Microbiol; 2006 Feb; 23(1):1-38. PubMed ID: 16942983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnostic dilemma: dual presentations of clinical mucosal bleeding and venous thrombosis associated with the presence of thrombophilia markers and mild reduction in von Willebrand factor.
    Favaloro EJ; Bonar R; Survela L; McDonald D; Koutts J; Sioufi J; Marsden K
    Lab Hematol; 2007; 13(4):128-34. PubMed ID: 18192144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory identification of factor inhibitors: the perspective of a large tertiary hemophilia center.
    Kershaw G; Jayakodi D; Dunkley S
    Semin Thromb Hemost; 2009 Nov; 35(8):760-8. PubMed ID: 20169512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HAIRVEQ 2006: evolution of laboratories' performance after different educational actions.
    Ventura M; Stramesi C; Pichini S; Ventura R; Pujadas M; Di Giovannandrea R; Zuccaro P; Pacifici R; Langohr K; de la Torre R
    Forensic Sci Int; 2008 Mar; 176(1):2-8. PubMed ID: 17980986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory performance in the World Federation of Hemophilia EQA programme, 2003-2008.
    Jennings I; Kitchen DP; Woods TA; Kitchen S; Walker ID; Preston FE
    Haemophilia; 2009 Mar; 15(2):571-7. PubMed ID: 19175423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multilaboratory peer assessment quality assurance program-based evaluation of anticardiolipin antibody, and beta2-glycoprotein I antibody testing.
    Favaloro EJ; Wong RC; Silvestrini R; McEvoy R; Jovanovich S; Roberts-Thomson P
    Semin Thromb Hemost; 2005 Feb; 31(1):73-84. PubMed ID: 15706478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2B or not 2B? Disparate discrimination of functional VWF discordance using different assay panels or methodologies may lead to success or failure in the early identification of type 2B VWD.
    Favaloro EJ; Bonar R; Meiring M; Street A; Marsden K;
    Thromb Haemost; 2007 Aug; 98(2):346-58. PubMed ID: 17721617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Filtered plasma as a potential cause of clinical misdiagnosis: inappropriate testing in a haematology laboratory.
    Favaloro EJ; Mohammed A; Coombs R; Mehrabani PA
    Br J Biomed Sci; 1995 Dec; 52(4):243-8. PubMed ID: 8555777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired functional coagulation inhibitors: review on epidemiology, results of a wet-workshop on laboratory detection, and implications for quality of inhibitor diagnosis.
    Dardikh M; Meijer P; van der Meer F; Favaloro EJ; Verbruggen B
    Semin Thromb Hemost; 2012 Sep; 38(6):613-21. PubMed ID: 22740185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.